Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Burchard

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
Infection|May 1, 1991
Characterization of 20 Entamoeba histolytica strains isolated from patients with HIV infectionG D Burchard, F T Hufert, D Mirelman
European Journal of Medical Research|September 27, 2000
Schistosomiasis and travel medicineM Lademann, G D Burchard, E C Reisinger
Parasitology Research|January 1, 1992
Adherence between Entamoeba histolytica trophozoites and undifferentiated or DMSO-induced HL-60 cellsG D Burchard, C Möslein, N W Brattig
Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology|July 1, 1986
Mycobacterium marinum infection in gnotobiotic nu/nu mice pretreated with cyclophosphamide and silicaG D Burchard, S Engelhorn, U Zillmann, et al.
Tropenmedizin Und Parasitologie|June 1, 1984
Comparative trial of oltipraz versus praziquantel in the treatment of urinary schistosomiasis in the GabonG D Burchard, P Kern, R Baltes, et al.
The American Journal of Tropical Medicine and Hygiene|September 28, 1998
Development of monoclonal antibodies specifically recognizing the cyst stage of Entamoeba histolyticaB Walderich, G D Burchard, J Knobloch, et al.
Archives of Medical Research|January 1, 1997
Development of monoclonal antibodies directed against cysts of Entamoeba histolytica and Entamoeba disparB Walderich, L Müller, J Knobloch, et al.
Tropical Medicine & International Health : TM & IH|March 1, 1997
Isoenzyme patterns of Blastocystis hominis patient isolates derived from symptomatic and healthy carriersA S Gericke, G D Burchard, J Knobloch, et al.
Parasite Immunology|January 1, 1992
Lysis of pathogenic and nonpathogenic Entamoeba histolytica by human complement: methodological analysisC Hamelmann, B Foerster, G D Burchard, et al.
Der Internist|July 1, 2008
[Severe ileocolitis refractory to standard medical treatment. A diagnostic dilemma]A Hofer, S Schmiedel, A W Lohse, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Infection|May 1, 1991
Characterization of 20 Entamoeba histolytica strains isolated from patients with HIV infectionG D Burchard, F T Hufert, D Mirelman
European Journal of Medical Research|September 27, 2000
Schistosomiasis and travel medicineM Lademann, G D Burchard, E C Reisinger
Parasitology Research|January 1, 1992
Adherence between Entamoeba histolytica trophozoites and undifferentiated or DMSO-induced HL-60 cellsG D Burchard, C Möslein, N W Brattig
Zentralblatt Fur Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology|July 1, 1986
Mycobacterium marinum infection in gnotobiotic nu/nu mice pretreated with cyclophosphamide and silicaG D Burchard, S Engelhorn, U Zillmann, et al.
Tropenmedizin Und Parasitologie|June 1, 1984
Comparative trial of oltipraz versus praziquantel in the treatment of urinary schistosomiasis in the GabonG D Burchard, P Kern, R Baltes, et al.
The American Journal of Tropical Medicine and Hygiene|September 28, 1998
Development of monoclonal antibodies specifically recognizing the cyst stage of Entamoeba histolyticaB Walderich, G D Burchard, J Knobloch, et al.
Archives of Medical Research|January 1, 1997
Development of monoclonal antibodies directed against cysts of Entamoeba histolytica and Entamoeba disparB Walderich, L Müller, J Knobloch, et al.
Tropical Medicine & International Health : TM & IH|March 1, 1997
Isoenzyme patterns of Blastocystis hominis patient isolates derived from symptomatic and healthy carriersA S Gericke, G D Burchard, J Knobloch, et al.
Parasite Immunology|January 1, 1992
Lysis of pathogenic and nonpathogenic Entamoeba histolytica by human complement: methodological analysisC Hamelmann, B Foerster, G D Burchard, et al.
Der Internist|July 1, 2008
[Severe ileocolitis refractory to standard medical treatment. A diagnostic dilemma]A Hofer, S Schmiedel, A W Lohse, et al.
Pageof 9